EU Kidney Consortium Proligen Awards Galapagos $665K Research Grant | GenomeWeb
NEW YORK (GenomeWeb News) - Galapagos has received a €500,000 ($665,000) grant from a European research consortium that aims to use genomics, proteomics, and functional genomics to help in the regeneration of injured kidneys, the company said today.
The grant was awarded by the Proligen consortium to Galapagos’ BioFocus DPI division, which identifies and validates drug targets and compound libraries using adenoviral agents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.